The Potential of Human Wharton’s Jelly Mesenchymal Stem Cells Secretome Based Topical Gel for Therapeutic Application
Background: Diabetic Foot Ulcer (DFU) might be worsened by neuropathy and vascular issues. This condition can cause 14.3% fatality, stressing the need for effective wound healing therapy. Wound healing is a complex biological process, and human Wharton's Jelly Mesenchymal Stem Cells (hWJMSCs) may help manage DFU treatment issues. This research focuses on utilizing a gel carrier to deliver bioactive substances from Wharton's Jelly Mesenchymal Stem Cells secretome (hWJ-MSCs-Sec) as a possible treatment for DFU. Methods: To maintain quality, hWJMSCs-Sec is thoroughly mixed with carbomer gel and freeze-dried. ELISA test is performed to determine the characterization of the gel of hWJMSCs-Sec such as Keratinocyte Growth Factor (KGF), Platelet-Derived Growth Factor (PDGF), Hepatocyte Growth Factor (HGF), Epidermal Growth Factor (EGF), and Heparin-Binding EGF-Like Growth Factor (HB-EGF). The antioxidant activity was also measured with Hydrogen peroxide (H2O2), Nitric oxide (NO), and Ferric Reducing Antioxidant Power (FRAP) assay. Proliferation assay was utilized using WST-8 and the wound healing potential was assessed via the migration cell ability of scratched-human skin fibroblast (BJ cells). Results: The freeze-dried hWJ-MSCs-Sec showed higher levels of KGF, HGF, PDGF, EGF, HB-EGF, and the antioxidant activities compared to fresh hWJ-MSCs-Sec. Additionally, the gel of freeze-dried hWJ-MSCs-Sec exhibited higher levels compared to the gel of fresh hWJMSCs-Sec. This was evidenced by faster closure of scratched wounds on BJ cells treated with hWJMSCs-Sec and freeze-dried hWJ-MSCs-Sec gel. Conclusion: The freeze-dried hWJ-MSCs-Sec gel exhibits superior quality compared to the non-freeze-dried hWJ-MSCs-Sec gel. This demonstrates that the freeze-drying procedure can maintain the bioactive chemicals found in hWJMSCs-Sec, potentially enhancing the efficacy of this gel in promoting cell regeneration for wound healing.
Authors
- Faradhina Salfa Nindya (ORCID: https://orcid.org/0009-0000-9547-6711)
- Fanny Rahardja (ORCID: https://orcid.org/0000-0003-2982-8437)
- Rizal Azis
- Ahmad Faried (ORCID: https://orcid.org/0000-0003-2967-8125)
- Wahyu Widowati (ORCID: https://orcid.org/0000-0002-5401-7794)
- Rimonta F. Gunanegara (ORCID: https://orcid.org/0000-0003-3053-1120)
- Fadhilah Haifa Zahiroh (ORCID: https://orcid.org/0000-0002-9661-8037)
- Annisa Firdaus Sutendi
- Renandy Kristianlie Ekajaya
Institutions
- Indonesia University of Education (ID)
- Maranatha Christian University (ID)
- University of Indonesia (ID)
- Padjadjaran University (ID)
Publication Details
- Journal
- Avicenna Journal of Medical Biotechnology
- Published
- 2024-10-19
- DOI
- https://doi.org/10.18502/ajmb.v16i4.16739
- Primary Topic
- Mesenchymal stem cell research
- Type
- article
- Field-Weighted Citation Impact
- 0.00